Download PDF
Semin Thromb Hemost 2022; 48(07): 842-849
DOI: 10.1055/s-0042-1753529
Review Article

The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review

Bianca O. Pîrlog
1   Department of Neurology, County Emergency Hospital, Cluj-Napoca, Romania
2   University of Medicine and Pharmacy “Iuliu Hațieganu” Cluj-Napoca, Romania
,
James C. Grotta
3   Memorial Hermann Hospital–Texas Medical Center, Houston, Texas
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Acute ischemic stroke (AIS) due to cerebral artery occlusion is often treated by thrombolytics or antithrombotic drugs. Thromboelastography (TEG) is a noninvasive test that provides a dynamic overview of the coagulation process. TEG may help guide thrombolytic and antithrombotic therapy in AIS. This article aims to highlight the potential use of TEG in AIS patients by reviewing available studies. We conducted a literature review, including PubMed and Cochrane library databases. The following keywords were used to find relevant studies: thromboelastography, TEG, acute ischemic stroke, stroke, coagulopathy, antiplatelet, and anticoagulant treatment. We identified 142 papers and after abstract review, we included 24 studies in this report. TEG identified a hypercoagulable state in AIS patients represented by short R, K, and greater α angle in all papers included. Modification of TEG parameters induced by intravenous thrombolysis was inconsistent but prolonged lysis (increased LY30) and weaker clots (lower maximum amplitude) were most frequent. TEG detected hypo-coagulopathy induced by dual antiplatelet therapy as well as antiplatelet drug resistance, with ticagrelor and aspirin having greater inhibition of platelet activity. A prolonged R-value seems to be the most reliable TEG parameter in detecting the anticoagulant effect of factor Xa inhibitor treatment. TEG might represent a useful point-of-care test for emergency decision-making in AIS patients and a tool for individualized treatment options. This hypothesis needs validation in a large cohort of prospectively studied AIS patients.

Keywords

thromboelastography - TEG - acute ischemic stroke - coagulopathy - antiplatelet treatment - anticoagulant treatment


Publication History

Article published online:
02 September 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Virani SS, Alonso A, Benjamin EJ. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics—2020 Update: a report from the American Heart Association. Circulation 2020; 141 (09) e139-e596
    CrossrefPubMedGoogle Scholar
  • 2 de Havenon A, Sheth K, Johnston KC. et al. Acute ischemic stroke interventions in the United States and racial, socioeconomic, and geographic disparities. Neurology 2021; 97 (23) e2292-e2303
    CrossrefPubMedGoogle Scholar
  • 3 Kleindorfer DO, Towfighi A, Chaturvedi S. et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52 (07) e364-e467
    Google Scholar
  • 4 Zhu J, Alexander GC, Nazarian S, Segal JB, Wu AW. Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010-2017. Pharmacotherapy 2018; 38 (09) 907-920
    CrossrefPubMedGoogle Scholar
  • 5 Chen A, Stecker E, A. Warden B. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc 2020; 9 (13) e017559
    CrossrefPubMedGoogle Scholar
  • 6 Bliden KP, Raviv G, Tantry US. et al. “Blueprinting” thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. J Thromb Thrombolysis 2019; 47 (02) 192-199
    CrossrefPubMedGoogle Scholar
  • 7 Gilbert BW, Bissell BD, Santiago RD, Rech MA. Tracing the lines: a review of viscoelastography for emergency medicine clinicians. J Emerg Med 2020; 59 (02) 201-215
    CrossrefPubMedGoogle Scholar
  • 8 Tyler PD, Yang LM, Snider SB, Lerner AB, Aird WC, Shapiro NI. New uses for thromboelastography and other forms of viscoelastic monitoring in the emergency department: a narrative review. Ann Emerg Med 2021; 77 (03) 357-366
    CrossrefPubMedGoogle Scholar
  • 9 Gilbert BW, Dingman JS, Huffman JB. Utilization of lysis percentage via thromboelastography for tissue plasminogen activator-induced symptomatic intracranial hemorrhage. Am J Emerg Med 2021; 43: 31-34
    CrossrefPubMedGoogle Scholar
  • 10 Liang C, Yang Y, He Z. et al. Comparison between thromboelastography and the conventional coagulation test in detecting effects of antiplatelet agents after endovascular treatments in acute ischemic stroke patients: a STROBE-compliant study. Medicine (Baltimore) 2020; 99 (10) e19447
    CrossrefPubMedGoogle Scholar
  • 11 Yuan Q, Yu L, Wang F. Efficacy of using thromboelastography to detect coagulation function and platelet function in patients with acute cerebral infarction. Acta Neurol Belg 2021; 121 (06) 1661-1667
    CrossrefPubMedGoogle Scholar
  • 12 Salem AM, Roh D, Kitagawa RS, Choi HA, Chang TR. Assessment and management of coagulopathy in neurocritical care. J Neurocritical Care 2019; 12 (01) 9-19
    CrossrefPubMedGoogle Scholar
  • 13 Zhao F, Yu P, Lv X. et al. Value of thromboelastography combined with anticoagulant detection in patients over 60 years of age with cardiovascular or cerebrovascular disease. Ann Palliat Med 2021; 10 (05) 5407-5416
    CrossrefPubMedGoogle Scholar
  • 14 Mallett SV, Cox DJA. Thrombelastography. Br J Anaesth 1992; 69 (03) 307-313
    CrossrefPubMedGoogle Scholar
  • 15 Gurbel PA, Bliden KP, Tantry US. et al. First report of the point-of-care TEG: a technical validation study of the TEG-6S system. Platelets 2016; 27 (07) 642-649
    CrossrefPubMedGoogle Scholar
  • 16 Sikora J, Karczmarska-Wódzka A, Bugieda J, Sobczak P. The importance of platelets response during antiplatelet treatment after ischemic stroke-between benefit and risk: a systematic review. Int J Mol Sci 2022; 23 (03) 1043
    CrossrefPubMedGoogle Scholar
  • 17 Dias JD, Haney EI, Mathew BA, Lopez-Espina CG, Orr AW, Popovsky MA. New-generation thromboelastography: comprehensive evaluation of citrated and heparinized blood sample storage effect on clot-forming variables. Arch Pathol Lab Med 2017; 141 (04) 569-577
    CrossrefPubMedGoogle Scholar
  • 18 Stettler GR, Sumislawski JJ, Moore EE. et al. Citrated kaolin thrombelastography (TEG) thresholds for goal-directed therapy in injured patients receiving massive transfusion. J Trauma Acute Care Surg 2018; 85 (04) 734-740
    CrossrefPubMedGoogle Scholar
  • 19 Einersen PM, Moore EE, Chapman MP. et al. Rapid thrombelastography thresholds for goal-directed resuscitation of patients at risk for massive transfusion. J Trauma Acute Care Surg 2017; 82 (01) 114-119
    CrossrefPubMedGoogle Scholar
  • 20 Weitzel NS, Weitzel LB, Epperson LE, Karimpour-Ford A, Tran ZV, Seres T. Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass. Anaesthesia 2012; 67 (10) 1158-1165
    CrossrefPubMedGoogle Scholar
  • 21 Samoš M, Škorňová I, Bolek T. et al. Viscoelastic hemostatic assays and platelet function testing in patients with atherosclerotic vascular diseases. Diagnostics (Basel) 2021; 11 (01) 143
    CrossrefPubMedGoogle Scholar
  • 22 Hunt H, Stanworth S, Curry N. et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev 2015; (02) CD010438
    PubMedGoogle Scholar
  • 23 Tantry US, Hartmann J, Neal MD. et al. The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation. Platelets 2022; 33 (04) 520-530
    CrossrefPubMedGoogle Scholar
  • 24 Schenk B, Görlinger K, Treml B. et al. A comparison of the new ROTEM® sigma with its predecessor, the ROTEMdelta. Anaesthesia 2019; 74 (03) 348-356
    CrossrefPubMedGoogle Scholar
  • 25 Ettinger MG. Thromboelastographic studies in cerebral infarction. Stroke 1974; 5 (03) 350-354
    CrossrefPubMedGoogle Scholar
  • 26 Elliott A, Wetzel J, Roper T. et al. Thromboelastography in patients with acute ischemic stroke. Int J Stroke 2015; 10 (02) 194-201
    CrossrefPubMedGoogle Scholar
  • 27 Liu Z, Chai E, Chen H, Huo H, Tian F. Comparison of thrombelastography (TEG) in patients with acute cerebral hemorrhage and cerebral infarction. Med Sci Monit 2018; 24: 6466-6471
    CrossrefPubMedGoogle Scholar
  • 28 Shi Z, Zheng WC, Fu XL, Fang XW, Xia PS, Yuan WJ. Hypercoagulation on thromboelastography predicts early neurological deterioration in patients with acute ischemic stroke. Cerebrovasc Dis 2018; 46 (3–4): 125-131
    PubMedGoogle Scholar
  • 29 Yu G, Kim YJ, Jeon SB, Kim WY. Thromboelastography for prediction of hemorrhagic transformation in patients with acute ischemic stroke. Am J Emerg Med 2020; 38 (09) 1772-1777
    CrossrefPubMedGoogle Scholar
  • 30 Yao X, Dong Q, Song Y, Wang Y, Deng Y, Li Y. Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke. Cerebrovasc Dis 2014; 38 (03) 182-190
    CrossrefPubMedGoogle Scholar
  • 31 Li J, Wu H, Hao Y, Yao X. Unstable carotid plaque is associated with coagulation function and platelet activity evaluated by thrombelastography. J Stroke Cerebrovasc Dis 2019; 28 (11) 104336
    CrossrefPubMedGoogle Scholar
  • 32 Huang RSP, McDonald MM, Wetzel JS. et al. Clot strength as measured by thrombelastography correlates with platelet reactivity in stroke patients. Ann Clin Lab Sci 2015; 45 (03) 301-307
    PubMedGoogle Scholar
  • 33 Rowe AS, Greene CL, Snider CC. et al. Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase. J Stroke Cerebrovasc Dis 2014; 23 (06) 1307-1311
    CrossrefPubMedGoogle Scholar
  • 34 McDonald MM, Wetzel J, Fraser S. et al. Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke. J Thromb Thrombolysis 2016; 41 (03) 505-510
    CrossrefPubMedGoogle Scholar
  • 35 McDonald MM, Archeval-Lao JM, Cai C. et al. Iodinated contrast does not alter clotting dynamics in acute ischemic stroke as measured by thromboelastography. Stroke 2014; 45 (02) 462-466
    CrossrefPubMedGoogle Scholar
  • 36 McDonald MM, Almaghrabi TS, Saenz DM. et al. Dual antiplatelet therapy is associated with coagulopathy detectable by thrombelastography in acute stroke. J Intensive Care Med 2020; 35 (01) 68-73
    CrossrefPubMedGoogle Scholar
  • 37 He D, Guo Y, Zhang Y. et al. Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke. J Neurointerv Surg 2022; 14 (07) 672-676
    CrossrefPubMedGoogle Scholar
  • 38 Sambu N, Hobson A, Curzen N. “Short” thrombelastography as a test of platelet reactivity in response to antiplatelet therapy: validation and reproducibility. Platelets 2011; 22 (03) 210-216
    CrossrefPubMedGoogle Scholar
  • 39 Hobson AR, Petley GW, Dawkins KD, Curzen N. A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography. Platelets 2007; 18 (07) 497-505
    CrossrefPubMedGoogle Scholar
  • 40 Xu ZH, Jiao JR, Yang R, Luo BY, Wang XF, Wu F. Aspirin resistance: clinical significance and genetic polymorphism. J Int Med Res 2012; 40 (01) 282-292
    CrossrefPubMedGoogle Scholar
  • 41 Sambu N, Radhakrishnan A, Englyst N, Weir N, Curzen N. “Aspirin resistance” in ischemic stroke: insights using short thrombelastography. J Stroke Cerebrovasc Dis 2013; 22 (08) 1412-1419
    CrossrefPubMedGoogle Scholar
  • 42 Cattaneo M. High on-treatment platelet reactivity–definition and measurement. Thromb Haemost 2013; 109 (05) 792-798
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Rao Z, Zheng H, Wang F. et al. High on-treatment platelet reactivity to adenosine diphosphate predicts ischemic events of minor stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2017; 26 (10) 2074-2081
    CrossrefPubMedGoogle Scholar
  • 44 Wang B, Li XQ, Ma N. et al. Association of thrombelastographic parameters with post-stenting ischemic events. J Neurointerv Surg 2017; 9 (02) 192-195
    CrossrefPubMedGoogle Scholar
  • 45 Yang Y, Chen W, Pan Y. et al. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA. Aging (Albany NY) 2020; 12 (20) 20085-20094
    CrossrefPubMedGoogle Scholar
  • 46 Bowry R, Fraser S, Archeval-Lao JM. et al. Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke. Stroke 2014; 45 (03) 880-883
    CrossrefPubMedGoogle Scholar
  • 47 Dias JD, Norem K, Doorneweerd DD, Thurer RL, Popovsky MA, Omert LA. Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med 2015; 139 (05) 665-673
    CrossrefPubMedGoogle Scholar
  • 48 Artang R, Anderson M, Nielsen JD. Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers. Res Pract Thromb Haemost 2019; 3 (03) 391-396
    CrossrefPubMedGoogle Scholar
  • 49 Bliden KP, Chaudhary R, Mohammed N. et al. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis 2017; 43 (04) 437-445
    CrossrefPubMedGoogle Scholar
  • 50 Özakin E, Özdemir AÖ, Şahin DG. et al. The relationship between thromboelastography and clinical outcome in acute stroke patients receiving thrombolytic therapy. Osman Tıp Derg 2020; 42 (05) 577-583
    PubMedGoogle Scholar
  • 51 de Villiers S, Swanepoel A, Bester J, Pretorius E. Novel diagnostic and monitoring tools in stroke: an individualized patient-centered precision medicine approach. J Atheroscler Thromb 2016; 23 (05) 493-504
    CrossrefPubMedGoogle Scholar
  • 52 Rosafio F, Vandelli L, Bigliardi G. et al. Usefulness of thromboelastography in the detection and management of tissue plasminogen activator-associated hyperfibrinolysis. J Stroke Cerebrovasc Dis 2017; 26 (02) e29-e31
    CrossrefPubMedGoogle Scholar
  • 53 Campello E, Farina F, Spiezia L. et al. Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke. Thromb Haemost 2016; 115 (06) 1231-1234
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Shao T, Cheng Y, Jin J. et al. A comparison of three platelet function tests in ischemic stroke patients with antiplatelet therapy. J Clin Neurosci 2020; 78: 91-96
    CrossrefPubMedGoogle Scholar
  • 55 Vedovati MC, Mosconi MG, Isidori F, Agnelli G, Becattini C. Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study. J Thromb Thrombolysis 2020; 49 (02) 251-258
    CrossrefPubMedGoogle Scholar
  • 56 Schäfer ST, Otto AC, Acevedo AC. et al. Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms. Thromb J 2021; 19 (01) 63
    CrossrefPubMedGoogle Scholar